• Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of "Moderate Buy" from Analysts

    ソース: Buzz FX / 10 3 2025 02:21:17   America/New_York


    Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Rating of "Moderate Buy" from Analysts Written by MarketBeat March 10, 2025 Share Link copied to clipboard. Remove Ads Beam Therapeutics Inc. ( NASDAQ:BEAM - Get Free Report ) has been a
    Read more...
シェアする